Yael Hayon

Syqe Medical Ltd. develops 3D-printed hand-held cannabis inhalers. It offers Syqe Inhaler Exo, a hospital version metered-dose cannabis inhaler for professional healthcare use, including pain clinics, cancer centers and intensive care units. The company was founded by Perry Davidson in 2011 and is headquartered in Tel Aviv, Israel.

Stemcell Medicine Ltd. develops and commercializes cellular therapies. It develops products from a number of tissue sources, such as adipose tissue stem cells for ischemic indications and from T cells for solid tumor-directed immunotherapies. The company was founded by Ehud Marom in 2010 and is headquartered in Jerusalem, IL.

LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA.